{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T23:10:11Z","timestamp":1767136211537,"version":"build-2238731810"},"update-to":[{"DOI":"10.1002\/14651858.cd011438","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T00:00:00Z","timestamp":1433203200000}}],"reference-count":99,"publisher":"Wiley","issue":"9","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd011438.pub2","type":"journal-article","created":{"date-parts":[[2015,6,2]],"date-time":"2015-06-02T21:47:32Z","timestamp":1433281652000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta\n                    <sub>2<\/sub>\n                    -agonists (LABA) for adults with asthma"],"prefix":"10.1002","volume":"2018","author":[{"given":"Kayleigh M","family":"Kew","sequence":"first","affiliation":[{"name":"BMJ; British Medical Journal Technology Assessment Group (BMJ-TAG); BMA House Tavistock Square London UK WC1H 9JR"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David JW","family":"Evans","sequence":"additional","affiliation":[{"name":"Lancaster University; Lancaster Health Hub; Lancaster UK LA1 4YG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Debbie E","family":"Anderson","sequence":"additional","affiliation":[{"name":"University of Strathclyde; Strathclyde Institute of Pharmacy and Biomedical Sciences; Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne C","family":"Boyter","sequence":"additional","affiliation":[{"name":"University of Strathclyde; Strathclyde Institute of Pharmacy and Biomedical Sciences; Glasgow UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2015,6,2]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaci.2011.06.004","article-title":"Tiotropium is noninferior to salmeterol in maintaining improved lung function in B16-Arg\/Arg patients with asthma","volume":"128","author":"Bateman","year":"2011","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0002|cit2","unstructured":"NCT00350207 A 16-week randomised, placebo-controlled, double-blind, double-dummy, parallel-group study comparing the efficacy and safety of tiotropium inhalation solution delivered by the Respimat Inhaler (2 actuations of 2.5 mcg once daily) with that of salmeterol from the hydrofluoroalkane metered dose inhaler (2 actuations of 25 mcg twice daily) in moderate persistent asthma patients with the B16-Arg\/Arg genotype clinicaltrials.gov\/show\/NCT00350207"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4997\/JRCPE.2010.425","article-title":"Tiotropium bromide in asthma patients: an alternative to inhaled long-acting beta-agonists?","volume":"40","author":"Lane","year":"2010","journal-title":"Journal of the Royal College of Physicians of Edinburgh"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0004|cit4","unstructured":"NCT00565266 Asthma Clinical Research Network (ACRN) Trial - Tiotropium bromide as an alternative to increased inhaled corticosteroid in patients inadequately controlled on a lower dose of inhaled corticosteroid (TALC) clinicaltrials.gov\/show\/NCT00565266"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.jaci.2013.08.003","article-title":"Predictors of response to tiotropium versus salmeterol in asthmatic adults","volume":"132","author":"Peters","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"18","key":"10.1002\/14651858.CD011438.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0007|cit7","unstructured":"NCT00706446 Genotype stratified treatment with anticholinergic vs. beta-agonist (long acting) and exacerbations (GABLE) clinicaltrials.gov\/show\/NCT00706446"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0008|cit8","unstructured":"NCT01172808 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae Inhaler (2.5 and 5 \u00b5g once daily) compared with placebo and salmeterol HFA MDI (50 \u00b5g twice daily) over 24 Weeks in moderate persistent asthma clinicaltrials.gov\/show\/NCT01172808"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0009|cit9","first-page":"377","article-title":"Phase III trials to investigate tiotropium as add-on therapy to inhaled corticosteroids for patients with symptomatic asthma: trial design and planned statistical analyses","volume":"68","author":"Casale","year":"2013","journal-title":"Allergy"},{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"Ab5","DOI":"10.1016\/j.jaci.2013.12.040","article-title":"Tiotropium Respimat (R) add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of T(H)2 inflammatory status","volume":"133","author":"Casale","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0011|cit11","unstructured":"NCT01172821 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae Inhaler (2.5 and 5 \u00b5g once daily) compared with placebo and salmeterol HFA MDI (50 \u00b5g twice daily) over 24 Weeks in moderate persistent asthma clinicaltrials.gov\/show\/NCT01172821"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0012|cit12","unstructured":"NCT01290874 Blacks and exacerbations on LABA vs. tiotropium (BELT) clinicaltrials.gov\/show\/NCT01290874"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.clinthera.2014.02.006","article-title":"Pulmonary function assessment in mild to moderate persistent asthma patients receiving montelukast, doxofylline, and tiotropium with budesonide: a randomized controlled study","volume":"36","author":"Rajanandh","year":"2014","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0014|cit14","unstructured":"Ilango K A clinical trial to study the effects of few anti asthmatic drug combinations on asthma patients apps.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2012\/08\/002915"},{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"41826","DOI":"10.1016\/j.clinthera.2014.12.008","article-title":"Assessment of montelukast, doxofylline, and tiotropium with budesonide for the treatment of asthma: which is the best among the second-line treatment? A randomized trial","volume":"37","author":"Rajanandh","year":"2015","journal-title":"Clinical Therapeutics"},{"issue":"7","key":"10.1002\/14651858.CD011438.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/1440-1681.12239","article-title":"Assessment of various second-line medications in addition to inhaled corticosteroid in asthma patients: a randomized trial","volume":"41","author":"Rajanandh","year":"2014","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0017|cit17","unstructured":"Chest Research Foundation A clinical trial comparing bronchodilator effects of two drugs, tiotropium bromide and formoterol fumarate each over 24 hours in subjects with asthma apps.who.int\/trialsearch\/Trial2.aspx?TrialID=CTRI\/2008\/091\/000306"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0018|cit18","unstructured":"Boehringer Ingelheim Pharma GmbH Co. KG The effect of tiotropium-bromide on deep inspiration-induced bronchodilation and airway responsiveness in asthma - tiotropium-bromide and lung mechanics apps.who.int\/trialsearch\/Trial2.aspx?TrialID=EUCTR2006-003385-34-NL"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0019|cit19","unstructured":"Saitama Medical University Randomized clinical study with tiotropium and formoterol\/budesonide in COPD with asthma apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000003618"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0020|cit20","unstructured":"EACC (Ehime Asthma COPD Conference) Add-on therapy for COPD receiving inhaled bronchodilators apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000005459"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0021|cit21","unstructured":"Fukuoka National Hospital Study for effects of tiotropium on smokers and non-smokers with bronchial asthma apps.who.int\/trialsearch\/Trial2.aspx?TrialID=JPRN-UMIN000010352"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0022|cit22","first-page":"91A","article-title":"Tiotropium as add-on therapy to ICS+LABA in patients with symptomatic severe asthma: spirometric assessment over 24 hours [Abstract]","volume":"144","author":"Corren","year":"2013","journal-title":"American College of Chest Physicians"},{"issue":"13","key":"10.1002\/14651858.CD011438.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1056\/NEJMoa1208606","article-title":"Tiotropium in asthma poorly controlled with standard combination therapy","volume":"367","author":"Kerstjens","year":"2012","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"AB1","DOI":"10.1016\/j.jaci.2012.12.680","article-title":"Efficacy of tiotropium in patients with asthma in relation to allergic status [Abstract]","volume":"131","author":"Vandewalker","year":"2013","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0025|cit25","unstructured":"NCT00546234 Assessing treatment options for smokers with asthma www.clinicaltrials.gov\/ct2\/show\/NCT00546234"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0026|cit26","unstructured":"National Jewish Health Examining the link between obesity, inflammation, and response to asthma medications clinicaltrials.gov\/show\/NCT00557180"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0027|cit27","unstructured":"NCT00557700 Study to investigate the effect of inhaled tiotropium bromide on neurokinin-A induced bronchoconstriction in patients with mild-to-moderate asthma www.clinicaltrials.gov\/ct2\/show\/NCT00557700"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0028|cit28","unstructured":"NCT00772538 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00c2\u00ae inhaler (5 mcg\/day) over 48 weeks as add-on controller therapy on top of usual care in patients with severe persistent asthma www.clinicaltrials.gov\/ct2\/show\/NCT00772538"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0029|cit29","unstructured":"NCT00776984 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (5 mcg\/day) over 48 weeks as add-on controller therapy on top of usual care in patients with severe persistent asthma www.clinicaltrials.gov\/ct2\/show\/NCT00776984"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0030|cit30","unstructured":"NCT01316380 A phase III, randomised, double-blind, placebo-controlled, parallel-group trial to evaluate efficacy and safety of tiotropium inhalation solution delivered via Respimat\u00ae inhaler (2.5 ug and 5 ug once daily) compared to placebo over 12 weeks in mild persistent asthma www.clinicaltrials.gov\/show\/NCT01316380"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0031|cit31","first-page":"877s","article-title":"Phase III trial of tiotropium as add-on therapy to low-dose inhaled corticosteroids for patients with symptomatic mild persistent asthma: Design and planned analyses [Abstract]","volume":"42 (Suppl 57)","author":"Paggiaro","year":"2013","journal-title":"European Respiratory Journal"},{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"AB4","DOI":"10.1016\/j.jaci.2013.12.039","article-title":"Tiotropium Respimat add-on to inhaled corticosteroids improves lung function in patients with symptomatic mild asthma: results from a phase III trial","volume":"133","author":"Paggiaro","year":"2014","journal-title":"Journal of Allergy and Clinical Immunology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0033|cit33","unstructured":"NCT01340209 A phase III randomised, double-blind, placebo-controlled, parallel-group trial to evaluate safety and efficacy of tiotropium inhalation solution delivered via Respimat inhaler (2.5 and 5 \u00b5g once daily) compared with placebo over 52 weeks in patients with moderate to severe persistent asthma www.clinicaltrials.gov\/show\/NCT01340209"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0034|cit34","unstructured":"NCT01573624 Evaluate the safety, efficacy and dose response of GSK573719 in combination with fluticasone furoate in subjects with asthma (ILA115938) clinicaltrials.gov\/show\/NCT01573624"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0035|cit35","unstructured":"NCT01641692 A multi-national, randomized, double-blind, placebo-controlled, 3-period crossover study with GSK 573719 as monotherapy in adult subjects with asthma www.clinicaltrials.gov\/ct2\/show\/NCT01641692"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0036|cit36","unstructured":"NCT01696214 SAPS: Smoking Asthmatics Pilot Study clinicaltrials.gov\/show\/NCT01696214"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0037|cit37","unstructured":"NCT02066298 Steroids in eosinophil negative asthma www.clinicaltrials.gov\/ct2\/show\/NCT02066298"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0038|cit38","unstructured":"NCT02127697 A randomized, double-blind, parallel group, 52-week study evaluating the efficacy, safety and tolerability of NVA237 in patients with poorly controlled asthma www.clinicaltrials.gov\/ct2\/show\/NCT02127697"},{"issue":"(Suppl 1)","key":"10.1002\/14651858.CD011438.pub2-BIB0039|cit39","first-page":"2","article-title":"Once-daily tiotropium in adolescents with symptomatic asthma despite inhaled corticosteroid treatment: a dose-ranging study [Abstract]","volume":"4","author":"Vogelberg","year":"2014","journal-title":"Clinical and Translational Allergy"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0040|cit40","doi-asserted-by":"crossref","unstructured":"Casale TB Dahl R Virchow JC Engel M Moroni-Zentgraf P Luehmann R Tiotropium respimat add-on therapy reduces exacerbation risk in patients with symptomatic moderate to severe asthma, independent of t helper 2 status A. Morikawa, Gunma University, Gunma, Japan American Thoracic Society 2015 A4193 MISC1 - AST","DOI":"10.1136\/thoraxjnl-2015-207770.288"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0041|cit41","unstructured":"DE Doherty M Castro P Moroni-Zentgraf M Engel R Luehmann R Buhl Tiotropium respimat add-on therapy improves lung function, as measured by peak expiratory flow, in adult patients across severities of symptomatic asthma A. Morikawa, Gunma University, Gunma, Japan American Thoracic Society 2015 A4258"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0042|cit42","doi-asserted-by":"crossref","unstructured":"Dahl R Bateman ED Casale T Pizzichini E Vandewalker M Virchow JC Once-daily tiotropium Respimat as add-on to at least medium- to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status 33rd congress of the european academy of allergy and clinical immunology 2014 515","DOI":"10.1136\/thoraxjnl-2014-206260.357"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0043|cit43","article-title":"Efficacy of tiotropium Respimat in adults with moderate asthma, by baseline LTRA use","volume":"46","author":"Dahl","year":"2015","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"A177","DOI":"10.1136\/thoraxjnl-2014-206260.357","article-title":"Once-daily tiotropium Respimat as add-on to at least medium-to high-dose ICS, with or without LABA, improves lung function in patients with symptomatic asthma, independent of allergic status","volume":"69","author":"Dahl","year":"2014","journal-title":"Thorax"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0045|cit45","unstructured":"FitzGerald JM Engel M Moroni-Zentgraf P Luehmann R Bleecker ER Once-daily tiotropium respimat add-on therapy improves symptom control across severities of symptomatic asthma, independent of allergic status A. Morikawa, Gunma University, Gunma, Japan American Thoracic Society 2015 A4263"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0046|cit46","article-title":"Once-daily tiotropium respimat add-on to ICS+\/-LABA improves control across asthma severities","volume":"44","author":"FitzGerald","year":"2014","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0047|cit47","first-page":"137","article-title":"Efficacy of once-daily tiotropium respimat 5UG from five phase III trials in adults with symptomatic asthma","volume":"20","author":"Frith","year":"2015","journal-title":"Respirology"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0048|cit48","doi-asserted-by":"crossref","DOI":"10.1378\/chest.2274996","article-title":"Once-daily tiotropium respimat add-on to medium-dose inhaled corticosteroids improves lung function and asthma control in adult patients with moderate symptomatic asthma, independent of prior long-acting-2-agonist use","volume":"148","author":"Greos","year":"2015","journal-title":"Chest"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0049|cit49","first-page":"A105","article-title":"Once-daily tiotropium Respimat add-on to maintenance therapy improves lung function in patients with moderate or severe symptomatic asthma, independent of T helper 2 inflammatory status","volume":"113","author":"Vandewalker","year":"2014","journal-title":"Annals of Allergy, Asthma & Immunology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0050|cit50","unstructured":"Yang WH Casale T Bateman ED Dahl R Pizzichini E Vandewalker M Tiotropium respimat add-on therapy reduces airflow obstruction in patients with symptomatic moderate asthma, independent of TH2 inflammatory status Allergy, Asthma, and Clinical Immunology A52"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0051|cit51","unstructured":"NCT01290874 Blacks and exacerbations on LABA vs. tiotropium (BELT) Http:\/\/clinicaltrials.gov\/show\/nct01290874 2014"},{"issue":"16","key":"10.1002\/14651858.CD011438.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/jama.2015.13277","article-title":"Anticholinergic vs long-acting \u03b22-agonist in combination with inhaled corticosteroids in Black adults with asthma: The BELT randomized clinical trial","volume":"314","author":"Wechsler","year":"2015","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"944","DOI":"10.12659\/MSM.907950","article-title":"Therapeutic effects of a long-acting cholinergic receptor blocker, tiotropium bromide, on asthma","volume":"24","author":"Zhang","year":"2018","journal-title":"Medical Science Monitor"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD002738.pub2","article-title":"Beclomethasone versus placebo for chronic asthma","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0055|cit55","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003135.pub4","article-title":"Fluticasone versus placebo for chronic asthma in adults and children","author":"Adams","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD011438.pub2-BIB0056|cit56","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011397","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS for adults with asthma","author":"Allison","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.330.7499.1037","article-title":"Prevalence of asthma","volume":"330","author":"Anderson","year":"2005","journal-title":"BMJ"},{"issue":"8","key":"10.1002\/14651858.CD011438.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1164\/rccm.200401-033OC","article-title":"Can guideline-defined asthma control be achieved? The gaining optimal asthma control study","volume":"170","author":"Bateman","year":"2004","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0059|cit59","first-page":"11","article-title":"Tiotropium in asthma: a systematic review","volume":"7","author":"Befekadu","year":"2014","journal-title":"Journal of Asthma and Allergy"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0060|cit60","unstructured":"Joint Formulary Committee British National Formulary www.medicinescomplete.com"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0061|cit61","unstructured":"Brozek J Oxman A Sch\u00fcnemann H GRADEPro Version 3.2 for Windows 2008"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0062|cit62","unstructured":"British Thoracic Society\/Scottish Intercollegiate Guidelines Network BTS\/SIGN British guideline on the management of asthma, October 2014 www.brit-thoracic.org.uk\/guidelines-and-quality-standards\/asthma-guideline\/"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0063|cit63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD007313.pub3","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus current best practice (including inhaled steroid maintenance), for chronic asthma in adults and children","author":"Cates","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0064|cit64","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010314.pub2","article-title":"Safety of regular formoterol or salmeterol in adults with asthma: an overview of Cochrane reviews","author":"Cates","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011438.pub2-BIB0065|cit65","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003137.pub5","article-title":"Addition to inhaled corticosteroids of long-acting beta2-agonists versus anti-leukotrienes for chronic asthma","author":"Chauhan","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"9","key":"10.1002\/14651858.CD011438.pub2-BIB0066|cit66","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009157.pub2","article-title":"Tiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary disease","author":"Chong","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0067|cit67","unstructured":"The Alfred Hospital Monash University National ICT Australia and the University of London Covidence 2013"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0068|cit68","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005535.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children","author":"Ducharme","year":"2008","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD011438.pub2-BIB0069|cit69","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005533.pub2","article-title":"Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma","author":"Ducharme","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0071|cit71","unstructured":"Electronic Medicines Compendium License extension 19th September 2014: Spiriva Respimat 2.5 micrograms solution for inhalation www.medicines.org.uk\/emc\/history\/20134"},{"issue":"9","key":"10.1002\/14651858.CD011438.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"692","DOI":"10.7326\/0003-4819-145-9-200611070-00012","article-title":"Safety and effectiveness of long-acting inhaled beta-agonist bronchodilators when taken with inhaled corticosteroids","volume":"146","author":"Ernst","year":"2006","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0073|cit73","unstructured":"United States Food Drug Administration FDA Drug Safety Communication: New safety requirements for long-acting inhaled asthma medications called long-acting beta-agonists (LABAs) www.fda.gov\/drugs\/drugsafety\/"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0074|cit74","unstructured":"Global Initiative for Asthma From the Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2014 www.ginasthma.org\/"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0075|cit75","unstructured":"International Union Against Tuberculosis and Lung Disease The Global Asthma Report 2011 theunion.org\/what-we-do\/publications\/technical\/global-asthma-report"},{"issue":"1","key":"10.1002\/14651858.CD011438.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1465-9921-7-73","article-title":"Muscarinic receptor signaling in the pathophysiology of asthma and COPD","volume":"7","author":"Gosens","year":"2006","journal-title":"Respiratory Research"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0077|cit77","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1 [updated March 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org"},{"issue":"7","key":"10.1002\/14651858.CD011438.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009285.pub3","article-title":"Tiotropium versus placebo for chronic obstructive pulmonary disease","author":"Karner","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011438.pub2-BIB0079|cit79","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009019.pub2","article-title":"Combination formoterol and budesonide as maintenance and reliever therapy versus combination inhaler maintenance for chronic asthma in adults and children","author":"Kew","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"12","key":"10.1002\/14651858.CD011438.pub2-BIB0080|cit80","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011437","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus higher dose ICS for adults with asthma","author":"Kew","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0081|cit81","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011721","article-title":"Long-acting muscarinic antagonists (LAMA) added to combination long-acting beta2-agonists and inhaled corticosteroids (LABA\/ICS) versus LABA\/ICS for adults with asthma","author":"Kew","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD011438.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/bcp.12123","article-title":"Emerging role of long acting muscarinic antagonists for asthma","volume":"77","author":"Lipworth","year":"2014","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0083|cit83","unstructured":"MECIR Methodological Expectations for the conduct of Cochrane Intervention Reviews editorial-unit.cochrane.org\/mecir"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0084|cit84","unstructured":"Medicines and Healthcare Products Regulatory Agency (MHRA) Drug safety update: tiotropium www.gov.uk\/drug-safety-update\/tiotropium"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0085|cit85","unstructured":"Medicines and Healthcare Products Regulatory Agency Asthma long-acting \u00df2 agonists: use and safety www.gov.uk\/government\/publications\/asthma-long-acting-ss2-agonists-use-and-safety"},{"issue":"1","key":"10.1002\/14651858.CD011438.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1476-5381.2010.01190.x","article-title":"Muscarinic receptor antagonists, from folklore to pharmacology; finding drugs that actually work in asthma and COPD","volume":"163","author":"Moulton","year":"2011","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0087|cit87","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The salmeterol multicenter asthma research trial","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"issue":"9","key":"10.1002\/14651858.CD011438.pub2-BIB0088|cit88","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010509.pub2","article-title":"Aclidinium bromide for stable chronic obstructive pulmonary disease","author":"Ni","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0089|cit89","unstructured":"National Institute for Health and Care Excellence NICE advice [KTT5] high-dose inhaled corticosteroids in asthma www.nice.org.uk\/Advice\/ktt5"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0090|cit90","unstructured":"Royal College of Physicians Why asthma still kills: the national review of asthma deaths www.rcplondon.ac.uk\/sites\/default\/files\/why-asthma-still-kills-full-report.pdf"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1097\/SMJ.0000000000000108","article-title":"Tiotropium in the treatment of patients with asthma","volume":"107","author":"Rashid","year":"2014","journal-title":"Southern Medical Journal"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0092|cit92","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2014"},{"issue":"2","key":"10.1002\/14651858.CD011438.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1378\/chest.14-1698","article-title":"What is the role of tiotropium in asthma? A systematic review with meta-analysis","volume":"147","author":"Rodrigo","year":"2015","journal-title":"Chest"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"904","DOI":"10.7326\/0003-4819-144-12-200606200-00126","article-title":"Meta-analysis: effect of long-acting beta-agonists on severe asthma exacerbations and asthma related deaths","volume":"144","author":"Salpeter","year":"2006","journal-title":"Annals of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD011438.pub2-BIB0095|cit95","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001281.pub2","article-title":"Long-acting beta2-agonists versus theophylline for maintenance treatment of asthma","author":"Tee","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD011438.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"654","DOI":"10.4187\/respcare.02703","article-title":"Tiotropium versus placebo for inadequately controlled asthma: a meta-analysis","volume":"59","author":"Tian","year":"2014","journal-title":"Respiratory Care"},{"issue":"3","key":"10.1002\/14651858.CD011438.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1183\/09031936.00005813","article-title":"Use of tiotropium Respimat Soft Mist Inhaler versus HandiHaler and mortality in patients with COPD","volume":"42","author":"Verhamme","year":"2013","journal-title":"European Respiratory Journal"},{"key":"10.1002\/14651858.CD011438.pub2-BIB0098|cit98","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1056\/NEJMoa1303342","article-title":"Tiotropium Respimat Inhaler and the risk of death in COPD","volume":"369","author":"Wise","year":"2013","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD011438.pub2-BIB0099|cit99","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD011438","article-title":"Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus addition of long-acting beta2-agonists (LABA) for adults with asthma","author":"Kew","year":"2015","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD011438.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:47:19Z","timestamp":1744148839000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD011438.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Airways Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,2]]},"references-count":99,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2018,9]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd011438.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,2]]}}}